	Positive affect and inflammation in women with breast cancer: A systematic review. Brain Behav Immun Health Frankowska M, Gliwinski M, Blazek M. PMID: 42502425 [PubMed]
	Seipin as a Putative Protective Factor for Breast Cancer: Evidence from Mendelian Randomization Analysis. Int J Womens Health Zeng J, Wang X, Fan L, Bai T, Jia H, Yang J. PMID: 42502347 [PubMed]
	Preoperative Axillary Nodal Burden in Early Breast Cancer: Assessment With Ultrasound-Guided Fine-Needle Aspiration Cytology and Sentinel Lymph Node Biopsy. Cureus Debnath M, Zim HZ, Syeed-Ul-Alam SM, Ahmed HS. PMID: 42502307 [PubMed]
	Association between adolescent alcohol consumption and cigarette smoking with adult risk of breast cancer: A systematic review and meta-analysis. Prev Med Hosseini F, Amin N, Dasari P, Ingman WV. PMID: 42501871 [PubMed - as supplied by publisher]
	Multicenter randomized effectiveness/implementation trial of a digital self-management support tool to improve the quality of life during adjuvant hormonal therapy for patients with early breast cancer: The HOPE trial. Contemp Clin Trials Franzoi MA, Michels S, Ball S, Barbier A, Serhal C, Bernatowiez A, Ferreira A, D'Andon JF, Gernier F, Morel A, Demetz J, Le Du F, Lapidari P, Vaz-Luis I. PMID: 42501860 [PubMed - as supplied by publisher]
	Awareness Is Not Enough: Global Evidence on Breast Cancer Knowledge and Self- Screening Practices Among Young Women. J Cancer Policy Ragendu R, Naman, Gupta R, Arya R, Jindal R, Kanozia R. PMID: 42501835 [PubMed - as supplied by publisher]
	Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases. Breast Grinda T, Heiling HM, Tayob N, Smith KL, Davis R, Cotter C, DeMeo MK, Santa-Maria CA, Van Poznak C, Moy B, Brufsky AM, Melisko ME, O'Sullivan CC, Isaacs C, Rauf Y, Nangia JR, Burns RT, Savoie J, Wolff AC, Winer EP, Mayer EL, Tolaney SM, Rimawi MF, Ruddy KJ, Rocque G, Krop IE, Lin NU, Freedman RA. PMID: 42501479 [PubMed - as supplied by publisher]
	Determining the best recipient vessel site for autologous microsurgical breast reconstruction using PAP flaps: An anatomical study. J Plast Reconstr Aesthet Surg Lhuaire M, Sedbon T, Biau D, Dramé M, Noel G, Hunsinger V, Garrido I, Derder M, Hivelin M, Delmas V, Abrahams P, Tavitian B, Fontaine C, Clement O, Lantieri L. PMID: 42501421 [PubMed - as supplied by publisher]
	Dermoglandular flaps for autologous augmentation during mastopexy after breast implant explantation: A five-year retrospective study. J Plast Reconstr Aesthet Surg Procikieviez IO, Procikieviez O. PMID: 42501420 [PubMed - as supplied by publisher]
	"Fat necrosis following deep inferior epigastric artery perforator flap breast reconstruction: A systematic review and meta-analysis". J Plast Reconstr Aesthet Surg Raman KS, Akdag A, Morel SBA, Chowdhury R, Kuper G, ElAbd R, Safran T, Vorstenbosch J. PMID: 42501419 [PubMed - as supplied by publisher]
	Cellular effects of combined Ctn-2 peptide and doxorubicin treatment in breast cancer cells: A preliminary study of membrane interaction, ROS production, and cell cycle distribution. Mol Biol Rep Sepúlveda AM, Manrique-Moreno M, Echeverri-Gaviria S, Santa-González GA. PMID: 42501149 [PubMed - indexed for MEDLINE]
	Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature. Technol Cancer Res Treat Morales-Duran JC, Osorno-Castillo K, Díaz GM. PMID: 42500935 [PubMed - indexed for MEDLINE]
	Pulmonary Tumor Thrombotic Microangiopathy Diagnosed by Right Heart Catheterization in a Patient With Breast Cancer: A Case Report. Cureus Tajima S, Nakata Y, Sanda K, Koshimo Y, Shigematsu M. PMID: 42500795 [PubMed]
	Synchronous HER2-Positive Breast and Gastric Cancers: A Dual Diagnostic Challenge With a Single Treatment Possibility. Cureus Morka J, Biernat P, Czerwinska A, Cybulska K, Cybulska D, Rysak A, Sobczak M, Mróz T. PMID: 42500763 [PubMed]
	PRR11 expression in early ER+/HER2-low breast cancer: Association with estrogen receptor positivity and exploratory analysis of prognostic significance. Oncol Lett Turkel A, Dogan M, Irkkan SC, Erdem HB, Bozdogan N, Bahsi T. PMID: 42500608 [PubMed]
	Research Advances in Drug Resistance Mechanisms to Anti-HER2 Therapy in HER2-Positive Breast Cancer. Oncol Res Huang C, Kong J, Ren H, Zhang W, Jiang S, Sheng X. PMID: 42500590 [PubMed - indexed for MEDLINE]
	Navigating the Metabolic-Genomic Paradigm: Mitochondrial Reprogramming as a Driver of Cancer Plasticity. Oncol Res Tzeng YT, Wen CY, Yong SB, Wen ZH, Chiang AJ, Li CJ. PMID: 42500587 [PubMed - indexed for MEDLINE]
	The Intratumoral Microbiota in Breast Cancer: Roles in Progression, Immunity, and Therapy. Oncol Res Wei Z, Cai J, Wang S, Li Y, Luo L, Chen J, Li F, Nie H, Gong K, Cai M. PMID: 42500581 [PubMed - indexed for MEDLINE]
	Breast Cancer Cell-Derived Exosomal miR-92b-3p Promotes Tumor Angiogenesis and Metastasis by Suppressing PTEN in Vascular Endothelial Cells. Oncol Res Yang T, Guan M, Guan X, Kang L, Wang X, Guan Y, Yang Y, Deng W, Wang G. PMID: 42500570 [PubMed - indexed for MEDLINE]
	Association of MT1A rs11640851, rs8052394 and rs11076161 Polymorphisms with the Risk of Developing Breast Cancer: A Haplotype-Based Case-Control Study and in Silico Analysis. Indian J Clin Biochem Shirvani M, Yadollahi A, Zamanzadeh Z, Abkar M, Yousefnia S. PMID: 42500341 [PubMed]

Articles 1 - 20 / 220448

Page 1 of 11023



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy